227 related articles for article (PubMed ID: 10728961)
21. Efficacy and safety of ibutilide for chemical cardioversion of atrial fibrillation and atrial flutter in cancer patients.
Bickford CL; Agarwal R; Urbauer DL; Durand JB; Lenihan DJ
Am J Med Sci; 2014 Apr; 347(4):277-81. PubMed ID: 23588261
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and cost analysis of ibutilide.
Dunn AB; White CM; Reddy P; Chow MS; Kluger J
Ann Pharmacother; 2000 Nov; 34(11):1233-7. PubMed ID: 11098333
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of ibutilide for termination of atrial fibrillation and flutter.
Ellenbogen KA; Clemo HF; Stambler BS; Wood MA; VanderLugt JT
Am J Cardiol; 1996 Oct; 78(8A):42-5. PubMed ID: 8903275
[TBL] [Abstract][Full Text] [Related]
24. Pharmacologic versus direct-current electrical cardioversion of atrial flutter and fibrillation.
Van Gelder IC; Tuinenburg AE; Schoonderwoerd BS; Tieleman RG; Crijns HJ
Am J Cardiol; 1999 Nov; 84(9A):147R-151R. PubMed ID: 10568674
[TBL] [Abstract][Full Text] [Related]
25. Acute conversion of atrial fibrillation and flutter: direct current cardioversion versus intravenously administered pure class III agents.
Singh BN
J Am Coll Cardiol; 1997 Feb; 29(2):391-3. PubMed ID: 9014994
[No Abstract] [Full Text] [Related]
26. Facilitating internal cardioversion of chronic atrial fibrillation with ibutilide--predictors of atrial defibrillation-threshold decrease.
Efremidis M; Sideris A; Batra R; Manolatos D; Xidonas S; Kardara D; Ekonomou D; Evagelou D; Filippatos G; Kardaras F
Med Sci Monit; 2004 Jun; 10(6):CR258-63. PubMed ID: 15173670
[TBL] [Abstract][Full Text] [Related]
27. [Success of pharmacologic cardioversion and electric cardioversion in patients with atrial fibrillation or flutter in a 5-year retrospective study].
Bugán V; Renker B; Brunclík P; Baraniková D; Augustín E
Vnitr Lek; 1994 Apr; 40(4):219-22. PubMed ID: 8184582
[TBL] [Abstract][Full Text] [Related]
28. Effectiveness and costs of chemical versus electrical cardioversion of atrial fibrillation.
de Paola AA; Figueiredo E; Sesso R; Veloso HH; Nascimento LO;
Int J Cardiol; 2003 Apr; 88(2-3):157-66. PubMed ID: 12714194
[TBL] [Abstract][Full Text] [Related]
29. Usefulness of ibutilide in facilitating successful external cardioversion of refractory atrial fibrillation.
Li H; Natale A; Tomassoni G; Beheiry S; Cooper P; Leonelli F; Easley A; Barrington W; Windle J
Am J Cardiol; 1999 Nov; 84(9):1096-8, A10. PubMed ID: 10569674
[TBL] [Abstract][Full Text] [Related]
30. The efficacy of pad placement for electrical cardioversion of atrial fibrillation/flutter: a systematic review.
Kirkland S; Stiell I; AlShawabkeh T; Campbell S; Dickinson G; Rowe BH
Acad Emerg Med; 2014 Jul; 21(7):717-26. PubMed ID: 25117151
[TBL] [Abstract][Full Text] [Related]
31. Safety and efficacy of ibutilide in cardioversion of atrial flutter and fibrillation.
Nair M; George LK; Koshy SK
J Am Board Fam Med; 2011; 24(1):86-92. PubMed ID: 21209348
[TBL] [Abstract][Full Text] [Related]
32. Facilitating transthoracic cardioversion of atrial fibrillation with ibutilide pretreatment.
Oral H; Souza JJ; Michaud GF; Knight BP; Goyal R; Strickberger SA; Morady F
N Engl J Med; 1999 Jun; 340(24):1849-54. PubMed ID: 10369847
[TBL] [Abstract][Full Text] [Related]
33. Ibutilide for pharmacological cardioversion of atrial fibrillation and flutter: impact of race on efficacy and safety.
Gowda RM; Punukollu G; Khan IA; Wilbur SL; Vasavada BC; Sacchi TJ
Am J Ther; 2003; 10(4):259-63. PubMed ID: 12845389
[TBL] [Abstract][Full Text] [Related]
34. [Immediate cardioversion of atrial fibrillation and atrial flutter lasting less than 90 days by ibutilide versus propafenone: a multicenter study].
Zhang HC; Guo JH; Fang Q; Zheng YA; Sun YM; Zhu WQ; Wan Z; Guo JX; Ge JB; Han SM
Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(12):798-801. PubMed ID: 15949393
[TBL] [Abstract][Full Text] [Related]
35. Ibutilide in rapid conversion of atrial flutter in octogenarians.
Antonicelli R; Testarmata P; Recanatini A
Drugs Aging; 2002; 19(10):787-91. PubMed ID: 12390055
[TBL] [Abstract][Full Text] [Related]
36. Single dose of ibutilide for conversion of persistent atrial fibrillation after radiofrequency ablation.
Hou Y; Fang PH; Liu J; Li XF; Hu JQ; Zhang S
Chin Med J (Engl); 2011 Mar; 124(5):710-3. PubMed ID: 21518563
[TBL] [Abstract][Full Text] [Related]
37. Transthoracic cardioversion of atrial fibrillation and flutter: standard techniques and new advances.
Kerber RE
Am J Cardiol; 1996 Oct; 78(8A):22-6. PubMed ID: 8903272
[TBL] [Abstract][Full Text] [Related]
38. Impact of prophylactic i.v. magnesium on the efficacy of ibutilide for conversion of atrial fibrillation or flutter.
Kalus JS; Spencer AP; Tsikouris JP; Chung JO; Kenyon KW; Ziska M; Kluger J; White CM
Am J Health Syst Pharm; 2003 Nov; 60(22):2308-12. PubMed ID: 14652979
[TBL] [Abstract][Full Text] [Related]
39. [Drug and electrical therapy of supraventricular tachyarrhythmias].
Heisel A; Jung J; Schieffer H
Z Kardiol; 2000; 89 Suppl 3():68-74. PubMed ID: 10810788
[TBL] [Abstract][Full Text] [Related]
40. Cost effectiveness of antiarrhythmic medications in patients suffering from atrial fibrillation.
Brüggenjürgen B; Kohler S; Ezzat N; Reinhold T; Willich SN
Pharmacoeconomics; 2013 Mar; 31(3):195-213. PubMed ID: 23444271
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
